In the current study, we described the identification along with the characterization of a whole new atypical opioid receptor with unique adverse regulatory properties in direction of opioid peptides.1 Our effects showed that ACKR3/CXCR7, hitherto generally known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be https://georgep950els2.blog-mall.com/profile